Studies on salivary flow in borderline hypertension

Area of Science:

• Physiology
• Pharmacology
• Hypertension Research

Background:

• Salivary flow is crucial for oral health and can be affected by various physiological conditions.
• Hypertension, a common cardiovascular condition, may influence autonomic nervous system regulation, including salivary gland function.

Purpose of the Study:

• To investigate differences in resting salivary flow between normotensive and borderline hypertensive individuals.
• To evaluate the impact of specific drugs (atropine, propranolol, phentolamine, neostigmine) on salivary secretion in these groups.

Main Methods:

• Comparative analysis of salivary production rates under resting conditions.
• Administration of pharmacological agents to assess their effects on salivary gland activity.
• Intravenous infusion of neostigmine to determine dose-response relationships for salivary stimulation.

Main Results:

• Resting salivary flow was significantly lower in borderline hypertensive subjects (0.51 g/min) compared to normotensive controls (0.85 g/min).
• Atropine decreased salivary secretion in both groups; propranolol and phentolamine had no significant effect.
• Neostigmine demonstrated a more pronounced stimulating effect on saliva production in normotensive subjects than in borderline hypertensive subjects.

Conclusions:

• Borderline hypertension is associated with reduced resting salivary flow.
• Findings suggest a reduced parasympathetic drive to the salivary glands in individuals with borderline hypertension.
• Autonomic nervous system dysregulation may play a role in the pathophysiology of borderline hypertension and its effects on salivary function.